
Fulcrum Therapeutics, Inc.
USD3.22
+0.08 (+2.55%)
CEO
Alexander C. Sapir
IPO Date
2019-07-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.10
Prev. Close
$3.14
Day Low
$3.10
Day High
$3.27
52W Low
$2.83
52W High
$15.74
Market Cap
$0.17B
Volume
5.59M
| 2 Jun 2026 |
| Piper Sandler |
| Overweight |
| Underweight |
| downgrade |
| 2 Jun 2026 | Leerink Partners | Outperform | Market Perform | downgrade |
| 11 Dec 2025 | Truist Securities | Buy | Buy | maintain |
| 9 Dec 2025 | B of A Securities | Underperform | Underperform | maintain |
| 8 Dec 2025 | RBC Capital | Sector Perform | Sector Perform | maintain |
| 8 Dec 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 8 Dec 2025 | Piper Sandler | Overweight | Overweight | maintain |